N-[2-[2-[2-[2-[3-[3-[3,5-bis[[(6aS)-2-methoxy-8-methylidene-11-oxo-6,6a,7,9-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]phenyl]prop-2-ynylamino]-3-oxopropoxy]ethoxy]ethoxy]ethoxy]ethyl]-3-(2,5-dioxopyrrol-1-yl)propanamide

C57H67N7O14 — CID 146450683

IUPACN-[2-[2-[2-[2-[3-[3-[3,5-bis[[(6aS)-2-methoxy-8-methylidene-11-oxo-6,6a,7,9-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]phenyl]prop-2-ynylamino]-3-oxopropoxy]ethoxy]ethoxy]ethoxy]ethyl]-3-(2,5-dioxopyrrol-1-yl)propanamide
SMILESC=C1C[C@H]2CNc3cc(OCc4cc(C#CCNC(=O)CCOCCOCCOCCOCCNC(=O)CCN5C(=O)C=CC5=O)cc(COc5cc6c(cc5OC)C(=O)N5CC(=C)C[C@H]5CN6)c4)c(OC)cc3C(=O)N2C1
InChIInChI=1S/C57H67N7O14/c1-37-22-42-31-60-46-29-50(48(71-3)27-44(46)56(69)63(42)33-37)77-35-40-24-39(25-41(26-40)36-78-51-30-47-45(28-49(51)72-4)57(70)64-34-38(2)23-43(64)32-61-47)6-5-11-58-53(66)10-14-73-16-18-75-20-21-76-19-17-74-15-12-59-52(65)9-13-62-54(67)7-8-55(62)68/h7-8,24-30,42-43,60-61H,1-2,9-23,31-36H2,3-4H3,(H,58,66)(H,59,65)/t42-,43-/m0/s1
InChIKeyADQGMWWPXPXJKL-MJPWBCPGSA-N
MW1074.20 g/mol
LogP3.61
Rot. Bonds27

About N-[2-[2-[2-[2-[3-[3-[3,5-bis[[(6aS)-2-methoxy-8-methylidene-11-oxo-6,6a,7,9-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]phenyl]prop-2-ynylamino]-3-oxopropoxy]ethoxy]ethoxy]ethoxy]ethyl]-3-(2,5-dioxopyrrol-1-yl)propanamide

N-[2-[2-[2-[2-[3-[3-[3,5-bis[[(6aS)-2-methoxy-8-methylidene-11-oxo-6,6a,7,9-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]phenyl]prop-2-ynylamino]-3-oxopropoxy]ethoxy]ethoxy]ethoxy]ethyl]-3-(2,5-dioxopyrrol-1-yl)propanamide (PubChem CID 146450683) has the molecular formula C57H67N7O14 and a molecular weight of 1074.20 g/mol. Its IUPAC name is N-[2-[2-[2-[2-[3-[3-[3,5-bis[[(6aS)-2-methoxy-8-methylidene-11-oxo-6,6a,7,9-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]phenyl]prop-2-ynylamino]-3-oxopropoxy]ethoxy]ethoxy]ethoxy]ethyl]-3-(2,5-dioxopyrrol-1-yl)propanamide.

Molecular Properties

Compound NameN-[2-[2-[2-[2-[3-[3-[3,5-bis[[(6aS)-2-methoxy-8-methylidene-11-oxo-6,6a,7,9-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]phenyl]prop-2-ynylamino]-3-oxopropoxy]ethoxy]ethoxy]ethoxy]ethyl]-3-(2,5-dioxopyrrol-1-yl)propanamide
PubChem CID146450683
Molecular FormulaC57H67N7O14
Molecular Weight1074.20 g/mol
Exact Mass1073.47
IUPAC NameN-[2-[2-[2-[2-[3-[3-[3,5-bis[[(6aS)-2-methoxy-8-methylidene-11-oxo-6,6a,7,9-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]phenyl]prop-2-ynylamino]-3-oxopropoxy]ethoxy]ethoxy]ethoxy]ethyl]-3-(2,5-dioxopyrrol-1-yl)propanamide
SMILESC=C1C[C@H]2CNc3cc(OCc4cc(C#CCNC(=O)CCOCCOCCOCCOCCNC(=O)CCN5C(=O)C=CC5=O)cc(COc5cc6c(cc5OC)C(=O)N5CC(=C)C[C@H]5CN6)c4)c(OC)cc3C(=O)N2C1
InChIInChI=1S/C57H67N7O14/c1-37-22-42-31-60-46-29-50(48(71-3)27-44(46)56(69)63(42)33-37)77-35-40-24-39(25-41(26-40)36-78-51-30-47-45(28-49(51)72-4)57(70)64-34-38(2)23-43(64)32-61-47)6-5-11-58-53(66)10-14-73-16-18-75-20-21-76-19-17-74-15-12-59-52(65)9-13-62-54(67)7-8-55(62)68/h7-8,24-30,42-43,60-61H,1-2,9-23,31-36H2,3-4H3,(H,58,66)(H,59,65)/t42-,43-/m0/s1
InChIKeyADQGMWWPXPXJKL-MJPWBCPGSA-N
XLogP3.61
TPSA234.10 Ų
H-Bond Donors4
H-Bond Acceptors16
Rotatable Bonds27
Heavy Atoms78
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 5001074.20
LogP ≤ 53.61
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1016

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'anil_di_alk_C(246)', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'}, {'alert_name': 'triple_bond', 'substructure': 'N/A'}

Analyze N-[2-[2-[2-[2-[3-[3-[3,5-bis[[(6aS)-2-methoxy-8-methylidene-11-oxo-6,6a,7,9-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]phenyl]prop-2-ynylamino]-3-oxopropoxy]ethoxy]ethoxy]ethoxy]ethyl]-3-(2,5-dioxopyrrol-1-yl)propanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[2-[2-[2-[2-[3-[3-[3,5-bis[[(6aS)-2-methoxy-8-methylidene-11-oxo-6,6a,7,9-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]phenyl]prop-2-ynylamino]-3-oxopropoxy]ethoxy]ethoxy]ethoxy]ethyl]-3-(2,5-dioxopyrrol-1-yl)propanamide?
The IUPAC name of N-[2-[2-[2-[2-[3-[3-[3,5-bis[[(6aS)-2-methoxy-8-methylidene-11-oxo-6,6a,7,9-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]phenyl]prop-2-ynylamino]-3-oxopropoxy]ethoxy]ethoxy]ethoxy]ethyl]-3-(2,5-dioxopyrrol-1-yl)propanamide (CID 146450683) is N-[2-[2-[2-[2-[3-[3-[3,5-bis[[(6aS)-2-methoxy-8-methylidene-11-oxo-6,6a,7,9-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]phenyl]prop-2-ynylamino]-3-oxopropoxy]ethoxy]ethoxy]ethoxy]ethyl]-3-(2,5-dioxopyrrol-1-yl)propanamide.
What is the SMILES notation for N-[2-[2-[2-[2-[3-[3-[3,5-bis[[(6aS)-2-methoxy-8-methylidene-11-oxo-6,6a,7,9-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]phenyl]prop-2-ynylamino]-3-oxopropoxy]ethoxy]ethoxy]ethoxy]ethyl]-3-(2,5-dioxopyrrol-1-yl)propanamide?
The canonical SMILES for N-[2-[2-[2-[2-[3-[3-[3,5-bis[[(6aS)-2-methoxy-8-methylidene-11-oxo-6,6a,7,9-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]phenyl]prop-2-ynylamino]-3-oxopropoxy]ethoxy]ethoxy]ethoxy]ethyl]-3-(2,5-dioxopyrrol-1-yl)propanamide is C=C1C[C@H]2CNc3cc(OCc4cc(C#CCNC(=O)CCOCCOCCOCCOCCNC(=O)CCN5C(=O)C=CC5=O)cc(COc5cc6c(cc5OC)C(=O)N5CC(=C)C[C@H]5CN6)c4)c(OC)cc3C(=O)N2C1.
What is the InChIKey of N-[2-[2-[2-[2-[3-[3-[3,5-bis[[(6aS)-2-methoxy-8-methylidene-11-oxo-6,6a,7,9-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]phenyl]prop-2-ynylamino]-3-oxopropoxy]ethoxy]ethoxy]ethoxy]ethyl]-3-(2,5-dioxopyrrol-1-yl)propanamide?
The InChIKey is ADQGMWWPXPXJKL-MJPWBCPGSA-N. The full InChI is InChI=1S/C57H67N7O14/c1-37-22-42-31-60-46-29-50(48(71-3)27-44(46)56(69)63(42)33-37)77-35-40-24-39(25-41(26-40)36-78-51-30-47-45(28-49(51)72-4)57(70)64-34-38(2)23-43(64)32-61-47)6-5-11-58-53(66)10-14-73-16-18-75-20-21-76-19-17-74-15-12-59-52(65)9-13-62-54(67)7-8-55(62)68/h7-8,24-30,42-43,60-61H,1-2,9-23,31-36H2,3-4H3,(H,58,66)(H,59,65)/t42-,43-/m0/s1.
What are the key properties of N-[2-[2-[2-[2-[3-[3-[3,5-bis[[(6aS)-2-methoxy-8-methylidene-11-oxo-6,6a,7,9-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]phenyl]prop-2-ynylamino]-3-oxopropoxy]ethoxy]ethoxy]ethoxy]ethyl]-3-(2,5-dioxopyrrol-1-yl)propanamide?
N-[2-[2-[2-[2-[3-[3-[3,5-bis[[(6aS)-2-methoxy-8-methylidene-11-oxo-6,6a,7,9-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]phenyl]prop-2-ynylamino]-3-oxopropoxy]ethoxy]ethoxy]ethoxy]ethyl]-3-(2,5-dioxopyrrol-1-yl)propanamide has a molecular weight of 1074.20 g/mol, XLogP of 3.61, 27 rotatable bonds, 4 hydrogen bond donors, and 16 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-[2-[2-[2-[3-[3-[3,5-bis[[(6aS)-2-methoxy-8-methylidene-11-oxo-6,6a,7,9-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]phenyl]prop-2-ynylamino]-3-oxopropoxy]ethoxy]ethoxy]ethoxy]ethyl]-3-(2,5-dioxopyrrol-1-yl)propanamide is sourced from PubChem (CID 146450683), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).